Elliot W. Ehrich
2014
In 2014, Elliot W. Ehrich earned a total compensation of $3.2M as Executive Vice President, Research and Development and Chief Medical Officer at Alkermes.
Compensation breakdown
| Non-Equity Incentive Plan | $470,000 |
|---|---|
| Option Awards | $1,530,141 |
| Salary | $468,120 |
| Stock Awards | $707,400 |
| Other | $13,100 |
| Total | $3,188,761 |
Ehrich received $1.5M in option awards, accounting for 48% of the total pay in 2014.
Ehrich also received $470K in non-equity incentive plan, $468.1K in salary, $707.4K in stock awards and $13.1K in other compensation.
Rankings
In 2014, Elliot W. Ehrich's compensation ranked 2,833rd out of 13,032 executives tracked by ExecPay. In other words, Ehrich earned more than 78.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,833 out of 13,032 | 78th |
Division Manufacturing | 1,005 out of 4,965 | 80th |
Major group Chemicals And Allied Products | 321 out of 1,690 | 81st |
Industry group Drugs | 250 out of 1,369 | 82nd |
Industry Pharmaceutical Preparations | 207 out of 1,042 | 80th |
Source: SEC filing on April 13, 2017.
Ehrich's colleagues
We found four more compensation records of executives who worked with Elliot W. Ehrich at Alkermes in 2014.